5
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Myxedema coma complicated by bilateral hygromas

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Summary

          Myxedema coma is an important differential diagnosis in critically ill patients. Early diagnosis and treatment are paramount but challenging due to a lack of diagnostic criteria. We report a case about a patient who suffered from untreated hypothyroidism for several years. Before the correct diagnosis was made, he was admitted three times due to severe constipation. Eventually, he developed myxedema coma in connection with a urinary tract infection. The course was complicated by recurrent seizures, and neuroimaging showed bilateral hygromas. Hormone replacement therapy resulted in complete recovery and regression of hygromas. To the best of our knowledge, this is the first time hygroma is reported in association with myxedema coma.

          Learning points
          • Myxedema coma is a difficult diagnosis to make due to a lack of diagnostic criteria.

          • Cardinal features include hypothermia, bradycardia, gastrointestinal symptoms, pericardial/pleural effusions and affection of CNS. Anemia and hyponatremia are common.

          • In case of suspected myxedema coma, neuroimaging should be a part of the evaluation in most cases.

          • There is a possible association between longstanding/severe hypothyroidism and hygroma.

          Related collections

          Most cited references10

          • Record: found
          • Abstract: found
          • Article: not found

          Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

          A number of recent advances in our understanding of thyroid physiology may shed light on why some patients feel unwell while taking levothyroxine monotherapy. The purpose of this task force was to review the goals of levothyroxine therapy, the optimal prescription of conventional levothyroxine therapy, the sources of dissatisfaction with levothyroxine therapy, the evidence on treatment alternatives, and the relevant knowledge gaps. We wished to determine whether there are sufficient new data generated by well-designed studies to provide reason to pursue such therapies and change the current standard of care. This document is intended to inform clinical decision-making on thyroid hormone replacement therapy; it is not a replacement for individualized clinical judgment.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Myxedema Coma: A New Look into an Old Crisis

            Myxedema crisis is a severe life threatening form of decompensated hypothyroidism which is associated with a high mortality rate. Infections and discontinuation of thyroid supplements are the major precipitating factors while hypothermia may not play a major role in tropical countries. Low intracellular T3 leads to cardiogenic shock, respiratory depression, hypothermia and coma. Patients are identified on the basis of a low index of suspicion with a careful history and examination focused on features of hypothyroidism and precipitating factors. Arrythmias and coagulation disorders are increasingly being identified in myxedema crisis. Thyroid replacement should be initiated as early as possible with careful attention to hypotension, fluid replacement and steroid replacement in an intensive care facility. Studies have shown that replacement of thyroid hormone through ryles tube with a loading dose and maintenance therapy is as efficacious as intravenous therapy. In many countries T3 is not available and oral therapy with T4 can be used effectively without major significant difference in outcomes. Hypotension, bradycardia at presentation, need for mechanical ventilation, hypothermia unresponsive to treatment, sepsis, intake of sedative drugs, lower GCS and high APACHE II scores and Sequential Organ Failure Assessment (SOFA) scores more than 6 are significant predictors of mortality in myxedema crisis. Early intervention in hypothyroid patients developing sepsis and other precipitating factors and ensuring continued intake of thyroid supplements may prevent mortality and morbidity associated with myxedema crisis.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A diagnostic scoring system for myxedema coma.

              To develop diagnostic criteria for myxedema coma (MC), a decompensated state of extreme hypothyroidism with a high mortality rate if untreated, in order to facilitate its early recognition and treatment.
                Bookmark

                Author and article information

                Journal
                Endocrinol Diabetes Metab Case Rep
                Endocrinol Diabetes Metab Case Rep
                EDM
                Endocrinology, Diabetes & Metabolism Case Reports
                Bioscientifica Ltd (Bristol )
                2052-0573
                25 May 2021
                2021
                : 2021
                : 21-0067
                Affiliations
                [1 ]Department of Endocrinology, Stavanger University Hospital , Stavanger, Norway
                [2 ]Department of Internal Medicine , Haugesund Hospital, Haugesund, Norway
                [3 ]Department of Radiology , Haugesund Hospital, Haugesund, Norway
                [4 ]Department of Anaesthesia , Haraldsplass Deaconess Hospital, Bergen, Norway
                [5 ]Department of Clinical Science , University of Bergen, Bergen, Norway
                Author notes
                Correspondence should be addressed to A-E Meling Stokland; Email: ann-elin.meling.stokland@ 123456sus.no
                Author information
                https://orcid.org/http://orcid.org/0000-0003-4496-615X
                Article
                EDM210067
                10.1530/EDM-21-0067
                8240815
                34156348
                7b5f9a40-5b0b-44da-8060-651d3581d95a
                © The authors

                This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License..

                History
                : 19 May 2021
                : 25 May 2021
                Categories
                Geriatric
                Male
                White
                Norway
                Thyroid
                Thyroid
                Neurology
                Unique/Unexpected Symptoms or Presentations of a Disease
                Unique/Unexpected Symptoms or Presentations of a Disease

                geriatric,male,white,norway,thyroid,neurology,unique/unexpected symptoms or presentations of a disease,june,2021

                Comments

                Comment on this article